101 – 110 of 183
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Treatment of prostate cancer with hormonal therapy in Europe
(
- Contribution to journal › Article
-
Mark
Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study
(
- Contribution to journal › Article
-
Mark
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.130-130(
- Contribution to journal › Published meeting abstract
-
Mark
European Association of Urology Position Statement on Screening for Prostate Cancer.
(
- Contribution to journal › Letter
-
Mark
The developing role of hormonal therapy in the treatment of prostate cancer.
(
- Contribution to journal › Article
-
Mark
The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
(
- Contribution to journal › Article
-
Mark
Brain irradiation: effects on normal brain parenchyma and radiation injury.
(
- Contribution to journal › Article
-
Mark
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates
(
- Contribution to journal › Scientific review
-
Mark
Prostate Cancer: To Treat or Not to Treat?
(
- Contribution to journal › Article